Transcatheter Mitral and Aortic Paravalvular Leak Closure: Innovations, Challenges, and Future Directions

View at publisher
Authors: Andrea Ruberti, Eduardo Flores‐Umanzor, Laura Palomo Sanchís, Thomas Pilgrim, Ander Regueiro, Philippe Garot, Reda Ibrahim, Guillermo Velázquez, Grzegorz A. Smolka, Omar Abdul-Jawad Altisent, Pedro Cepas-Guillén, Sebastien Hascoët
+13 more Giovanni Occhipinti, I Cruz-Gonzalez, Marta Sitges, B. Vidal, Gerard Martí-Aguasca, Eustaquio Maria Onorato, Mark Osten, Josep Rodes-Cabau, Gabor G. Toth, Nicolas Dumonteil, Patrick A. Calvert, Eric M. Horlick, XR Freixa
Cited by: 1
References: 69

Abstract

Paravalvular leak (PVL) is a well-known complication of valve replacement, occurring in up to 10% of aortic and 17% of mitral prosthetic valves. Although many leaks are small and clinically insignificant, ≈1% to 5% of cases are associated with clinically relevant complications, such as heart failure symptoms and hemolytic anemia. Surgical reoperation is currently considered the first-line option; however, it encompasses high mortality and morbidity risks. In the past years, transcatheter PVL closure has proven to be highly effective when performed in experienced centers. Transcatheter PVL closure requires advanced imaging modalities, specialized materials, and techniques, reflecting the high complexity of the procedure. We review the complex nature of PVL, including its diagnostic workup and the available transcatheter treatment strategies, with a special focus on the treatment of mitral and aortic PVL using plugging devices.

Fields of Study & Subjects

Cardiac Valve Diseases and Treatments Infective Endocarditis Diagnosis and Management Aortic Disease and Treatment Approaches

Publication details

Journal / source
Circulation Cardiovascular Interventions
Publisher
Ovid Technologies (Wolters Kluwer Health)
Volume
19
Issue
3
Pages
e015984–e015984
Publication date
19 February 2026
Language
EN